SCHEMBL9022641

SCHEMBL9022641

O=C(O)c1cccn1CCc1ccco1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.48
TSHR P16473 5/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 6/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSD17B10 Q99714 3/20 0.39
POLB P06746 2/20 0.39
RECQL P46063 2/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
ADRA1D P25100 1/20 0.38
GAA P10253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9022199 0.91 CNR2 (0.44) CNR2TSHRCYP1A2CYP3A4CYP2C19
SCHEMBL9022821 0.88 CNR2 (0.53) CNR2TSHRCYP1A2CYP3A4CYP2C19
SCHEMBL9023262 0.76 NPC1 (0.49) CNR2ALDH1A1SMN1; SMN2TDP1POLB
SCHEMBL1664496 0.75 LMNA (0.44) ALDH1A1TDP1POLBRECQLKDM4E
SCHEMBL11332213 0.74 CNR2 (0.49) CNR2TSHRCYP1A2CYP3A4CYP2C19
SCHEMBL28706581 0.72 TSHR (0.41) CNR2TSHRCYP1A2CYP3A4CYP2C19
Bicarbonate SCHEMBL29658892 0.72 ALDH1A1 (0.52) TSHRCYP3A4ALDH1A1HPGDTDP1
SCHEMBL27680360 0.72 CA12 (0.49) CNR2ALDH1A1KDM4E
SCHEMBL5776620 0.72 MEN1 (0.42) CNR2ALDH1A1SMN1; SMN2TDP1POLB
SCHEMBL1938751 0.72 LMNA (0.42) ALDH1A1TDP1POLBRECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0381141-B1 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
CN-1022754-C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method MERRELL DOW PHARMA (US) 1993-11-17 CN disclosed
US-5041554-A Replace steroids in treatment of inflammatory diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-20 US disclosed
US-5039695-A Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-13 US disclosed
CN-1044653-A The new aryl or the heteroaryl-I-alkyl-pyrroles-2-carboxylic acid that are used for the treatment of the pathological state of interleukin-I mediation MERRELL DOW PHARMA (US) 1990-08-15 CN disclosed
EP-0381141-A2 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions MERRELL PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed
EP-0381142-A2 Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed